Shaw, A. T., Bearz, A., Camidge, D. R., Bauman, J. R., Solomon, B., & Felip Font, E. (2021). Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.

Shaw, Alice Tsang, A. Bearz, D. R. Camidge, J. R. Bauman, Benjamin Solomon, and Enriqueta Felip Font. Intracranial and Extracranial Efficacy of Lorlatinib in Patients With ALK-positive Non-small-cell Lung Cancer Previously Treated With Second-generation ALK TKIs. 2021.

Shaw, Alice Tsang, et al. Intracranial and Extracranial Efficacy of Lorlatinib in Patients With ALK-positive Non-small-cell Lung Cancer Previously Treated With Second-generation ALK TKIs. 2021.